Watchdog considers $1.6 billion merger of pathology testing companies
The RACGP says the merger will disadvantage GPs and patients.
The RACGP is urging the national consumer watchdog to stop Australian Clinical Labs taking over Healius Pathology, on the grounds a pathology testing supergroup would harm GP practices with co-located collection centres.
The college made the plea to the ACCC, which is investigating the impact on bulk-billing and prices if Australian Clinical Labs is allowed to purchase all Healius shares.
